Visual compatibility of vancomycin and heparin in peritoneal dialysis solutions
Strong, D.K.; Ho, W.; Nairn, J.G.
American Journal of Hospital Pharmacy 46(9): 1832-1833
1989
ISSN/ISBN: 0002-9289 PMID: 2801723 Document Number: 341790
Document emailed within 1 workday
Related Documents
Fourtounas, C.; Savidaki, E.; Roumelioti, M.; Dousdampanis, P.; Hardalias, A.; Kalliakmani, P.; Papachristou, E.; Drakopoulos, A.; Goumenos, D.S.; Vlachojannis, J.G. 2006: Acid-base profile and predictors of metabolic acidosis in patients undergoing peritoneal dialysis with lactate- and bicarbonate-buffered peritoneal dialysis solutions Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 22: 187-191Hassan, K.; Hassan, F.; Hassan, D.; Edgem, R.; Hassan, S. 2015: Do diabetic patients receiving conventional dialysis solutions benefit from peritoneal dialysis? Minerva Urologica e Nefrologica 67(4): 365-374
Montenegro, J. 2008: Phosphorus (P) chelant in dialysis: efficacy and cost. Peritoneal dialysis solutions Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 28(Suppl 5): 53-57
Olszowska, A.; Baczyński, D. 1998: Alternative dialysis solutions in continuous ambulatory peritoneal dialysis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 5(29): 307-309
Pawlaczyk, K.; Garcia-Lopez, E.; Kuzlan-Pawlaczyk, M.; Heimbürger, O.; Bergström, J.; Breborowicz, A.; Lindholm, B. 2001: The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(Suppl 3): S359-S361
Goel, S.; Misra, M.; Saran, R.; Khanna, R. 1998: The rationale for, and role of, heparin in peritoneal dialysis Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 14: 111-115
Bruno, M.; Gabella, P.; Ramello, A. 2000: Use of amino acids in peritoneal dialysis solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(Suppl 2): S166-S171
Paap, C.M.; Nahata, M.C. 1990: Stability of cefotaxime in two peritoneal dialysis solutions American Journal of Hospital Pharmacy 47(1): 147-150
Martis, L. 1995: Industry perspectives on biocompatibility of peritoneal dialysis solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 15(7 Suppl): S96-S99
Garcia-Lopez, E.; Lindholm, B.; Tranaeus, A. 2000: Biocompatibility of new peritoneal dialysis solutions: clinical experience Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(Suppl 5): S48-S56
Krediet, R.T.; Zweers, M.M.; Ho-dac-Pannekeet, M.M.; van der Wal, A.C.; Smit, W.; Douma, C.E.; Mateijsen, M.A.; Struijk, D.G. 1999: The effect of various dialysis solutions on peritoneal membrane viability Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 19(Suppl 2): S257-S266
Lameire, N.; Faict, D. 1994: Peritoneal dialysis solutions containing glycerol and amino acids Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 14(Suppl 3): S145-S151
Nolph, K.D.; Twardowski, Z.J.; Khanna, R.; Prowant, B.F.; Ponferrada, L.P.; Schmidt, L.M.; Moore, H.L. 1990: Tidal peritoneal dialysis with racemic or L-lactate solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 10(2): 161-164
Cueto-Manzano, A.M.; Rojas-Campos, E.; Martínez-Ramírez, H.éc.R.; Valera-González, I.; Medina, M.; Monteón, F.; Ruiz, N.; Becerra, M.; Palomeque, M.A.; Cortés-Sanabria, L. 2006: Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(3): 341-348
Dooley, D.P.; Tyler, J.R.; Wortham, W.G.; Harrison, L.S.; Starnes, W.F.; Collins, G.R.; Ozuna, I.S.; Violet, P.L.; Ward, J.A. 2003: Prolonged stability of antimicrobial activity in peritoneal dialysis solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 23(1): 58-62
Zareie, M.; Keuning, E.D.; ter Wee, P.M.; Beelen, R.H.J.; van den Born, J. 2004: Improvement of a chronic rat model for peritoneal dialysis by using heparin-coated catheters Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 20: 150-154
Manley, H.J.; Grabe, D.W.; Norcross, M.; Cooperman, T.A.; Stinchcomb, A.L.; Hass, M.; Bailie, G.R. 2000: Stability of amphotericin B-lipid complex (Abelcet) in peritoneal dialysis solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(1): 87-90
Larpent, L.; Verger, C. 1990: The need for using an enzymatic colorimetric assay in creatinine determination of peritoneal dialysis solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 10(1): 89-92
Diaz-Buxo, J.A. 2007: Peritoneal dialysis solutions low in glucose degradation products: clinical experience and outcomes Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 23: 132-134
Martikainen, T.A.; Teppo, A.-M.; Grönhagen-Riska, C.; Ekstrand, A.V. 2005: Glucose-free dialysis solutions: inductors of inflammation or preservers of peritoneal membrane? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 25(5): 453-460